Anti-infectives
Understanding the Complexities of Urinary Tract Infections (UTIs)
UTIs are often viewed as routine infections, but for millions of people, they can be recurring, disruptive, and far more complex than they appear.
Behind the science US edition
Investors
We announced our second quarter 2026 results on Tuesday, 28 July.
Press releases
- Hibsago (bepirovirsen) approved in the US for the treatment of chronic hepatitis B (CHB)
- Jemperli (dostarlimab-gxly) approved in US as first and only immunotherapy for adults with MSI-H/dMMR locally advanced rectal cancer
- Viola Davis partners with GSK to educate adults 50 and older about their shingles risk
GSK Global links
Visit our Global site for additional features